Breathe, published by the European Respiratory Society Journals Ltd, is a prominent open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. With an ISSN of 1810-6838 and an E-ISSN of 2073-4735, this journal has been contributing to scholarly discourse since 2008. Nestled in the United Kingdom, it serves as a vital platform for researchers, clinicians, and educators, particularly in the areas of respiratory pathophysiology, diagnostic methods, and therapeutic interventions. Currently classified in the third quartile (Q3) for pulmonary and respiratory medicine, Breathe ranks 91st out of 155 in Scopus, reflecting its growing influence in the discipline. The journal aims to publish high-quality, peer-reviewed research that fosters collaboration and innovation in lung health, making significant strides toward improving patient outcomes. Whether you are a seasoned professional or an up-and-coming researcher, Breathe offers a wealth of knowledge and resources to support your work in this crucial area of medicine.

YONSEI MEDICAL JOURNAL, published by the Yonsei University College of Medicine, stands as a premier open-access journal in the field of medicine since its inception. With an ISSN of 0513-5796 and an E-ISSN of 1976-2437, this esteemed journal has been diligently serving the scientific community since 1963, featuring crucial research developments that span multiple aspects of medical science. Hailing from South Korea and ranked in the Q2 category for Medicine (miscellaneous) in the 2023 Scopus rankings, it holds an impressive rank of #115 out of 636 in General Medicine, placing it in the 81st percentile. The journal is dedicated to facilitating the dissemination of knowledge through its open-access platform, which has been pivotal in enhancing visibility and accessibility for researchers, professionals, and students worldwide. As it continues to publish cutting-edge findings, YONSEI MEDICAL JOURNAL not only contributes to ongoing medical education but also fosters groundbreaking research that shapes the future of healthcare.

Chiropractic & Manual Therapies is a premier open-access journal published by BMC, dedicated to advancing the fields of Chiropractic, Complementary and Alternative Medicine, and Physical Therapy. Since its inception in 2011, the journal has established its reputation within the academic community, evidenced by its Q1 ranking in Chiropractics and Complementary and Alternative Medicine, and Q2 in Physical Therapy, Sports Therapy, and Rehabilitation as of 2023. With an impressive Scopus ranking placing it in the top 5% for Chiropractics and maintaining a strong presence in the complementary medicine sector, Chiropractic & Manual Therapies serves as a critical platform for researchers, practitioners, and students seeking to disseminate innovative findings and practical advancements in manual therapies. Located in the United Kingdom, the journal not only promotes accessible research but also contributes to the ongoing discourse in healthcare practices, ensuring valuable insights are shared widely among professionals and the academic community.

The Eurasian Journal of Pulmonology is a premier open access journal dedicated to advancing the field of respiratory medicine and thoracic diseases. Published by KARE PUBL since 1999, the journal serves as an invaluable platform for researchers, clinicians, and students, facilitating the dissemination of innovative research findings and clinical practices. With an emphasis on high-quality and peer-reviewed articles, it aims to foster collaboration and knowledge sharing among professionals in the pulmonology community. Although the journal’s precise impact factor is currently not specified, its commitment to openness and accessibility ensures a broad reach and engagement with vital research, making it a critical resource for those in the academic and medical fields. The journal is based in Istanbul, Turkiye, further enriching its contributions to the Eurasian medical landscape and global health discourse.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

ACTA MEDICA OKAYAMA is a respected peer-reviewed journal published by Okayama University Medical School, dedicated to advancing knowledge in the fields of biochemistry, genetics, and general medicine. Established in 1972, this journal serves as a vital platform for researchers, professionals, and students to disseminate their findings and engage with ongoing scientific discussions. Based in Japan, it holds notable rankings within its categories, including Q3 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q4 in Medicine (miscellaneous), indicating its emerging influence in a competitive field. Although it currently does not provide open access options, the journal strives to ensure high-quality and impactful research is accessible to a wide audience, contributing to both the regional and international academic landscape. With convergence of research until the year 2024, ACTA MEDICA OKAYAMA is poised to play an increasingly significant role in the evolution of medical and biological sciences.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

Frontiers in Medicine, published by FRONTIERS MEDIA SA, is a distinguished open-access journal that has been at the forefront of medical research since its inception in 2014. With an impressive 2023 Q1 ranking in the field of miscellaneous medicine and a notable Scopus rank of #93 out of 636—placing it in the 85th percentile in the general medicine category—this journal serves as a pivotal resource for academics and practitioners. Hailing from Switzerland, Frontiers in Medicine aims to publish high-quality research that addresses the most pressing issues in the medical field, fostering innovation and collaboration among researchers worldwide. By facilitating open access to comprehensive, peer-reviewed articles, the journal enhances the dissemination of knowledge and encourages interdisciplinary dialogues essential for medical advancement. Whether you're a researcher, a clinician, or a student, this journal is an invaluable tool for staying abreast of the latest developments in medicine.